Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Lantheus Holdings (LNTH)

Lantheus Holdings (LNTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 742,376
  • Shares Outstanding, K 39,248
  • Annual Sales, $ 343,370 K
  • Annual Income, $ 40,520 K
  • 60-Month Beta 1.40
  • Price/Sales 2.20
  • Price/Cash Flow 13.84
  • Price/Book 7.32

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.31
  • Number of Estimates 1
  • High Estimate 0.31
  • Low Estimate 0.31
  • Prior Year 0.24
  • Growth Rate Est. (year over year) +29.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.80 +6.26%
on 01/14/20
21.42 -11.69%
on 12/18/19
-1.84 (-8.89%)
since 12/17/19
3-Month
17.80 +6.26%
on 01/14/20
21.84 -13.39%
on 11/12/19
+0.02 (+0.08%)
since 10/17/19
52-Week
16.09 +17.56%
on 01/22/19
29.80 -36.53%
on 07/01/19
+2.42 (+14.64%)
since 01/17/19

Most Recent Stories

More News
Lantheus Holdings Announces Senior Leadership Appointment

Lantheus Holdings, Inc. (NASDAQ: LNTH) ("Lantheus"), parent company of Lantheus Medical Imaging, Inc. ("LMI"), a leader in the development, manufacture and commercialization of innovative diagnostic imaging...

LNTH : 18.92 (+0.29%)
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Progenics Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Progenics Pharmaceuticals, Inc. ("Progenics"...

LNTH : 18.92 (+0.29%)
PGNX : 4.69 (-0.42%)
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Progenics Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Progenics Pharmaceuticals, Inc. ("Progenics" or "the Company") (NASDAQ:...

LNTH : 18.92 (+0.29%)
PGNX : 4.69 (-0.42%)
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation Regarding the November 12, 2019 Registration Statement of Progenics Pharmaceuticals, Inc.

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating the Registration Statement...

LNTH : 18.92 (+0.29%)
PGNX : 4.69 (-0.42%)
Lantheus Enters into Strategic Collaboration with CarThera for Use of Microbubbles in Combination with SonoCloud(R) System for Treatment of Glioblastoma

Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. ("LMI"), a global leader in the development, manufacture and commercialization of innovative diagnostic...

LNTH : 18.92 (+0.29%)
Lantheus Holdings to Present at the 31st Annual Piper Jaffray Healthcare Conference

Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. ("LMI"), a global leader in the development, manufacture and commercialization of innovative...

LNTH : 18.92 (+0.29%)
Lantheus Releases Comprehensive Strategic Plan for Progenics

--Lantheus' In-Place Infrastructure and Commercial Capabilities Will Ensure the Progress of AZEDRA, and the PyL and 1095 Programs

LNTH : 18.92 (+0.29%)
Lantheus Holdings (LNTH) Tops Q3 Earnings and Revenue Estimates

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 12.00% and 2.11%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

LNTH : 18.92 (+0.29%)
Lantheus Holdings: 3Q Earnings Snapshot

NORTH BILLERICA, Mass. (AP) _ Lantheus Holdings Inc. (LNTH) on Thursday reported third-quarter net income of $4.9 million.

LNTH : 18.92 (+0.29%)
Lantheus Holdings, Inc. Reports Third Quarter 2019 Financial Results

Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. ("LMI"), a global leader in the development, manufacture and commercialization of innovative diagnostic...

LNTH : 18.92 (+0.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade LNTH with:

Business Summary

Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations,...

See More

Key Turning Points

2nd Resistance Point 19.39
1st Resistance Point 19.15
Last Price 18.92
1st Support Level 18.63
2nd Support Level 18.34

See More

52-Week High 29.80
Fibonacci 61.8% 24.56
Fibonacci 50% 22.94
Fibonacci 38.2% 21.33
Last Price 18.92
52-Week Low 16.09

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar